Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA

Nat Commun. 2023 Feb 24;14(1):1051. doi: 10.1038/s41467-023-36717-4.

Abstract

A new variant of Streptococcus pyogenes serotype M1 (designated 'M1UK') has been reported in the United Kingdom, linked with seasonal scarlet fever surges, marked increase in invasive infections, and exhibiting enhanced expression of the superantigen SpeA. The progenitor S. pyogenes 'M1global' and M1UK clones can be differentiated by 27 SNPs and 4 indels, yet the mechanism for speA upregulation is unknown. Here we investigate the previously unappreciated expansion of M1UK in Australia, now isolated from the majority of serious infections caused by serotype M1 S. pyogenes. M1UK sub-lineages circulating in Australia also contain a novel toxin repertoire associated with epidemic scarlet fever causing S. pyogenes in Asia. A single SNP in the 5' transcriptional leader sequence of the transfer-messenger RNA gene ssrA drives enhanced SpeA superantigen expression as a result of ssrA terminator read-through in the M1UK lineage. This represents a previously unappreciated mechanism of toxin expression and urges enhanced international surveillance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Australia
  • Bacterial Proteins / genetics
  • Exotoxins / genetics
  • Humans
  • Mutation
  • Scarlet Fever* / epidemiology
  • Streptococcal Infections*
  • Streptococcus pyogenes / genetics
  • Superantigens
  • United Kingdom

Substances

  • Superantigens
  • Bacterial Proteins
  • Exotoxins